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Background: We examined the relationship between central blood pressure (BP), brachial BP with carotid
atherosclerosis and microvascular complications in type 2 diabetes mellitus (T2DM).
Methods: We recruited 201 patients who were evaluated for central BP, brachial BP, carotid ultrasonography,
brachial-ankle pulse wave velocity (baPWV), ankle-brachial index (ABI) and microvascular complications. Central BP
were calculated using a radial automated tonometric system.
Results: Agreement between central BP and brachial BP was very strong (concordance correlation coefficient
between central and brachial SBP = 0.889, between central and brachial PP = 0.816). Central pulse pressure (PP)
was correlated with mean carotid intima-media thickness (CIMT), baPWV and ABI, whereas brachial PP was
borderline significantly correlated with CIMT. The prevalence of nephropathy(DN) and retinopathy(DR) according
to the brachial PP tertiles increased, the prevalences of microvascular complications were not different across central
PP tertiles. In multivariate analysis, the relative risks (RRs) for the presence of DR were 1.2 and 4.6 for the brachial
PP tertiles 2 and 3 when compared with the first tertile. Also, the RRs for the presence of DN were 1.02 and 3 for
the brachial PP tertiles 2 and 3 when compared with the first tertile.
Conclusions: Agreement of central BP and brachial BP was very strong. Nonetheless, this study showed that higher
brachial PP levels are associated with increased probability for the presence of microvascular complications such
as DR/DN. However, there are no associations with central SBP and central PP with microvascular complications.
Central BP levels than brachial BP are correlated with surrogate marker of macrovascular complications.
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Type 2 diabetesBackground
Blood pressure (BP) management is important for the
prevention and management of cardiovascular disease
(CVD) and microvascular complications in T2DM [1].
Brachial BP remains the standard of reference for the
evaluation and management of BP, and has been a key
element in predicting target organ damage (TOD) and* Correspondence: hanna@schmc.ac.kr
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unless otherwise stated.CVD [2]. However, there is increasing evidence that central
BP may be a more sensitive indicator of CV risk than bra-
chial BP in specific groups [3-5]. In a study of American
Indians, central BP more strongly related to the extent
of carotid atherosclerosis, vascular hypertrophy and CV
events than brachial BP [4]. The Conduit Artery Function
Evaluation study demonstrated the superiority of central
BP to brachial BP as a CV predictor in hypertensive
patients [5]. In patients with T2DM, a few studies have
documented that increased augmentation of central BP
is associated with increases in CIMT [6,7]. However,
to our knowledge, no study has compared central BPd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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micro-and macrovascular complications in patients with
T2DM.
Pulse pressure (PP) is traditionally thought of as a
marker of arterial stiffness and has been suggested as an
independent CV risk factor [8,9]. Recent several studies
reported that brachial PP may be significantly associated
with CIMT [10,11]. Brachial PP is reportedly a better
predictor of coronary heart disease events than other BP
components in patients with T2DM [9]. However, the
significance of central PP versus brachial PP regarding
macrovascular complications in patients with diabetes
remains to be clarified. In addition, some authors sug-
gested that brachial PP is associated with microvascular
complications, although some authors disagree [12-14].
Central BP is most accurately measured by an invasive
method. It has been evaluated noninvasively by mathem-
atically transforming the radial artery pulse waveform to
the aortic pulse waveform recently [15,16]. Although a few
studies evaluated the relations of brachial and central
pressures to carotid atherosclerosis, no studies have repor-
ted the relative importance of central and brachial BP in
to microvascular complications in patients with T2DM.
Therefore, the aim of this study was to evaluate the value
of central BP and brachial BP components in relation to
microvascular complications and surrogate markers of




We recruited 201 patients with T2DM who were evalu-
ated for central BP, carotid ultrasonography and stand-
ard brachial BP measurement at the diabetes clinic of
Soonchunhyang University Bucheon Hospital, from June
2012 to July 2012. We reviewed detailed demographic
data, biochemical data and clinical history using medical
records. Participants provided written informed consent
for the use of their data for research. This study was
reviewed and approved by the Institutional Review
Board of Soonchunhyang University College Medicine,
Bucheon Hospital.
Measurement of central BP
Central BP was evaluated noninvasively by mathematic-
ally transforming the radial artery pulse waveform to the
aortic pulse waveform with an automated tonometric
system, HEM-9000AI (Omron Healthcare, Kyoto, Japan)
in a sitting position after at least 5 min of rest. The radial
artery pressure waveform was recorded for 10 sec with the
HEM-9000AI system. The radial pulse wave was calibra-
ted to brachial BP, measured with an automated oscillo-
metric device. From the average radial pulse wave form,
the corresponding ascending aortic pulse wave form wasderived, using a validated generalized transfer function in-
corporated in the software (Omron Healthcare), which
also provided the calculated central BP and the calculated
central Aix. The measurements of blood pressure were
performed twice by the same trained observer in same day
at intervals of at least one minute.Carotid atherosclerosis
Carotid atherosclerosis was assessed by the use of a model
SSA-660A high-resolution B-mode ultrasonograph device
(Toshiba, Tokyo, Japan) performed with an ultrasound
scanner equipped with a 12-MHz linear-array transducer.
IMT measurements were performed on the right and left
common carotid arteries 1.0 cm proximal to the origin
of the bulb and the mean IMT values were calculated.
Carotid IMT thickening was defined as mean CIMT ≥
1.0 mm [17,18].Microvascular complications
Diabetic nephropathy (DN) was defined using albumin-
uria, which was measured by radioimmunoassay (Immu-
notech, Prague, Czech Republic). Albumin excretion rate
(AER) in the range of 20-200 μg/min or urine albumin
30-300 mg/g creatinine was defined as microalbuminuria,
and AER > 200 μg/min or urine albumin ≥ 300 mg/g cre-
atinine as overt proteinuria. Patients were considered to
have nephropathy if they displayed microalbuminuria or
overt proteinuria.
Diabetic retinopathy (DR) was evaluated by experi-
enced ophthalmologists while the patients’ pupils were
dilated. If needed, fluorescein angiography was per-
formed. DR was classified as normal, nonproliferative
and proliferative retinopathy [19]. Patients were consid-
ered to have retinopathy if they displayed the nonproli-
ferative or proliferative stage.
Diabetic peripheral neuropathy (DPN) was diagnosed
with recommendation by the Expert Committee of
Korean Diabetes Neuropathy Study Group, as: the pres-
ence of typical symptoms using the Michigan Neuropathy
Screening Instrument (MNSI) and compatible findings on
neurologic screening examinations or electrophysiologic
studies [20,21]. Although electrophysiological studies are
not essential, current perception threshold (CPT) test was
performed in all patients using a Neurometer CPT/C
(Neurotron, Baltimore, MD).
Cardiac autonomic neuropathy (CAN) was assessed by
autonominc function test (AFT). CAN was assessed by
the five standard cardiovascular reflex tests according to
the Ewing’s protocol [22]. The severity of CAN was
quantitated by summation of points obtained from each
of the five tests, where each test was given a point of 0,
0.5, or 1 if it yielded a normal, borderline, or abnormal
value, respectively. CAN was defined as the presence of
Table 1 General characteristics of the study populations
Age (year) 55.8 ± 11.3
Men/Women (%) 115/86 (57.2/42.8)
Duration of DM(year) 8.5 ± 7.5
Hypertension, n (%) 96 (47.8%)
Body mass index (kg/m2) 24.9 ± 3.1
Central SBP (mmHg) 121.7 ± 17
Central PP (mmHg) 49.4 ± 13.3
Brachial PP (mmHg) 49 ±12
Systolic BP (mmHg) 121.4 ± 15.6
Diastolic BP (mmHg) 72.3 ± 10
Total Cholesterol (mg/dL) 162.7 ± 36.2
Triglyceride (mg/dL)* 121 (88, 169)
HDL-cholesterol (mg/dL) 48 ± 13
LDL-cholesterol (mg/dL) 94.7 ± 33
hsCRP (mg/dL)* 0.09 (0.05, 0.18)
HbA1C (%) 7.6 ± 1.6
eGFR (mL/min/1.73 m2) 76 ± 18
Mean CIMT (mm) 0.62 ± 0.14
Mean ABI 1.14 ± 0.07
Mean baPWV (cm/sec) 1555 ± 405
HOMA-IR* 2.81 (1.89, 4.5)
DPN, n(%) 56 (28%)
CAN, n (%) 65 (32.6%)
Diabetic nephropathy, n (%) 47 (23.4%)
Diabetic retinopathy, n (%) 39 (19.4%)
Data are reported as mean ± standard deviation (SD) for variables which are
normally distributed or as median (interquartile range) for variables which are
not normally distributed or as number of participants (percentages). DM:
diabetes mellitus; SBP: systolic blood pressure; PP: pulse pressure; HDL: high
density lipoprotein; LDL: low density lipoprotein; hsCRP: high-sensitivity
C-reactive protein; HbA1c: hemoglobin A1c; eGFR: estimated glomerular
filtration rate; CIMT: carotid intima-media thickness; ABI: ankle-brachial index;
baPWV: brachial-ankle pulse wave velocity; HOMA-IR: homeostasis model
assessment-insulin resistance; DPN: diabetic peripheral neuropathy; CAN:
cardiac autonomic neuropathy.
*Natural logarithmic transformation were performed before analysis.
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points ≥ 2 [23,24].
An automated device (VP-1000; Colin, Komaki, Japan)
was used to measure arterial baPWV and ABI. The insu-
lin resistance status was evaluated by the HOMA-IR
index, which was calculated by the formula: [fasting insu-
lin (uIU/mL) × fasting blood glucose (mmol/L)]/22.5. The
HOMA-IR score was available only in 164 patients not
receiving exogenous insulin.
Statistical analyses
Data are presented as mean ± standard deviation (SD)
for variables normally distributed or as median (inter-
quartile range) for variables not normally distributed or
as number of participants (percentages). Non-normally
distributed variables of, triglyceride, high-sensitivity C-
reactive proein (hsCRP) and HOMA-IR were transformed
as natural logarithm before analysis. The concordance
correlation coefficient between central BP and brachial BP
was measured to evaluate the agreement between two
variables. The categorical variables of the groups were
compared by Chi-square test. Correlation between BP and
other clinical parameters were analyzed by Spearman’s
correlation analysis. The significance of the mean differ-
ences including several parameters of BP between patients
with and those without microvascular complications was
evaluated with Student’s t-test. Patients were divided into
theree groups by the tertiles of central or brachial PP
levels, respectively. One-way ANOVA was used to eva-
luate differences of means among tertiles of central or
brachial PP groups. The prevalence of microvascular com-
plications and carotid atherosclerosis according to the
tertile of brachial PP, central SBP and central PP were
analyzed using Chi-square test. Relationships of central
BP and brachial BP with microvascular complications
were determined in multivariate logistic regression ana-
lyses. Two-tailed p < 0.05 was considered significant. Stat-
istical analyses were performed with SPSS, version 18
(SPSS, Chicago, IL).
Results
General characteristics of the study populations
A total of 201 patients with T2DM (115 males) partici-
pated in this cross-sectional study. Clinical and biochem-
ical characteristics of the study subjects are presented in
Table 1. The mean age was 55.8 years and duration of DM
was 8.5 years. Ninety-six (47.8% of total, 57% of men and
43% of women) were treated for hypertension. Eighty-
three (86.5%) were treated with angiotensin converting
enzyme inhibitor (ACEI) or/and angiotensin receptor
blocker (ARB), 41 (47.2%) were treated with calcium
channel blocker, 14 (14.6%) with beta blockers and 15
(15.6%) with diuretics. Central and brachial blood pressures
and parameters of carotid atherosclerosis are presented inTable 1. The prevalence of DN, DR, DPN and CAN was
23.4%, 19.4%, 28% and 32.6%, respectively.
Bivariate correlations between central and brachial BP with
carotid atherosclerosis, vascular stiffness and clinical CV
risk factors
The concordance correlation coefficient between central
SBP and brachial SBP was 0.889 and between central PP
and brachial PP was 0.816 (Figure 1).
The correlations of central BP components (central
SBP, central PP) and brachial BP components (brachial
SBP, brachial PP) to carotid atherosclerosis, vascular
stiffness and other clinical variables are presented in
Table 2. Central SBP showed significant positive cor-
relation with mean ABI and baPWV (r = 0.162, p = 0.04,
Figure 1 Concordance correlation coefficient between central BP and brachial BP components. (A) Concordance correlation between
central SBP and brachial SBP. (B) Concordance correlation between central PP and brachial PP.
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correlated positively with total cholesterol, triglyceride and
baPWV and were not correlated ABI. Brachial DBP
showed negative correlations with age and duration of
DM and positive correlations with eGFR and triglyceride
(data not shown). Central PP was correlated positively
with age, ABI and baPWV and negatively with eGFR.Table 2 Bivariate correlations between central and brachial b
Central SBP Centr
r p r
Age (years) 0.131 0.06 0.431
Duration of DM (years) 0.019 0.78 0.126
BMI (kg/m2) 0.049 0.49 −0.015
Central SBP (mmHg) - - 0.767
Central PP (mmHg) 0.767 <0.001 -
Brachial SBP (mmHg) 0.875 <0.01 0.596
Brachial DBP (mmHg) 0.643 <0.01 0.077
Brachial PP (mmHg) 0.643 <0.01 0.748
HbA1C (%) 0.06 0.4 −0.039
eGFR (mL/min/1.73 m2) −0.083 0.29 −0.217
Total cholesterol (mg/dL) 0.143 0.06 0.068
Triglyceride (mg/dL) 0.108 0.15 −0.057
HDL-C (mg/dL) 0.051 0.504 0.035
LDL-C (mg/dL) 0.121 0.16 0.049
HsCRP (mg/dL) 0.1 0.31 0.072
HOMA-IR 0.05 0.62 0.02
Mean CIMT (mm) 0.082 0.38 0.235
Mean ABI 0.162 0.04 0.185
Mean baPWV (cm/sec) 0.449 <0.01 0.531
DM: diabetes mellitus; BMI: body mass index; SBP: systolic blood pressure; PP: pulse
HDL: high density lipoprotein; LDL: low density lipoprotein; hsCRP: high-sensitivity C
CIMT: carotid intima-media thickness; ABI: ankle-brachial index; baPWV: brachial-ank
Spearman’s correlation analysis was used for the statistical analyses.Brachial PP was not correlated with ABI and was corre-
lated positively with duration of DM, age, eGFR, and
baPWV. (r = 0.234, p < 0.01 for duration of DM; r = 0.473,
p < 0.01 for age; r = −0.349, p < 0.01 for eGFR; r = 0.576,
p < 0.01 for baPWV). Univariate analysis revealed that
central PP is significantly correlated with CIMT (r = 0.235,
p = 0.01) and brachial PP values also showed positivelood pressure with clinical variables
al PP Brachial SBP Brachial PP
p r p r p
<0.001 0.119 0.091 0.473 <0.01
0.083 0.082 0.26 0.234 <0.01
0.834 0.091 0.2 0.04 0.56
<0.001 0.875 <0.001 0.544 <0.01
- 0.596 <0.001 0.748 <0.001
<0.001 - - 0.692 <0.01
0.274 0.66 <0.001 0.005 0.94
<0.001 0.692 <0.001 - -
0.5 0.042 0.561 −0.034 0.64
0.006 −0.152 0.459 −0.349 <0.01
0.376 0.194 0.011 0.139 0.07
0.451 0.164 0.029 0.016 0.84
0.647 0.08 0.293 0.035 0.65
0.565 0.127 0.138 0.066 0.44
0.469 0.072 0.466 0.037 0.44
0.844 0.071 0.481 0.068 0.5
0.01 0.068 0.467 0.197 0.047
<0.019 0.083 0.297 0.069 0.38
<0.001 0.477 <0.001 0.576 <0.01
pressure; HbA1c: hemoglobin A1c; eGFR: estimated glomerular filtration rate;
-reactive protein; HOMA-IR: homeostasis model assessment-insulin resistance;
le pulse wave velocity.
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(r = 0.197, p = 0.047).
Carotid atherosclerosis, vascular stiffness and other
clinical variables according to the tertile of central PP and
brachial PP
Comparison of carotid atherosclerosis, vascular stiffness
and clinical variables among tertile groups of central PP
or brachial PP is shown in Tables 3 and 4. The mean
CIMT, baPWV and ABI was significantly increased pro-
gressively across central PP tertiles (p = 0.04, p < 0.001,
and p = 0.023, respectively). In addition, the age and dur-
ation of DM were significantly increased progressively
across central PP tertiles (Table 3). Stage of DN (normoal-
buminuria, microalbuminuria, overt proteinuria) among
tertile groups of central PP was not different (p = 0.69).
Whereas stage of DN among tertile groups of brachial PP
was significantly different (p = 0.02). The age and duration
of DM were significantly increased progressively, eGFR
were decreased progressively across brachial PP tertilesTable 3 Difference of mean values of the clinical variables acc
1st tertile
Central PP (mmHg) 37.1 ± 4.2
Central SBP (mmHg) 108.2 ± 11.8
Brachial SBP (mmHg) 111.4 ± 11.9
Brachial DBP (mmHg) 71.1 ± 10
Brachial PP (mmHg) 40.3 ± 7.2
Age (years) 51.2 ± 11
BMI (kg/m2) 24.9 ± 3.4
Duration of DM (years) 7.5 ± 5.4
HbA1C (%) 7.7 ± 1.6
Total cholesterol (mg/dL) 158.3 ± 34.6
Triglycerides (mg/dL) 112 (91, 169)
HDL-C (mg/dL) 47.5 ± 11.9
LDL-C (mg/dL) 93.5 ± 32.6
eGFR (mL/min/1.73 m2) 79.5 ± 16.1
Diabetic nephropathy, n (%)
No albuminuria 55 (36.9)
Microalbuminuria 13 (35)
Overt proteinuria 2 (26.8)
HOMA-IR 2.6 (1.8, 4.5)
hsCRP (mg/dL) 0.09 (0.05, 0.13)
Mean CIMT (mm) 0.58 ± 0.14
Mean baPWV (cm/sec) 1385 ± 253
Mean ABI 1.13 ± 0.06
Data are shown as mean ± SD, median (interquartile range) or number (percentage
PP: pulse pressure; SBP: systolic blood pressure; SBP: systolic blood pressure; DBP: d
hemoglobin A1c; HDL: high density lipoprotein; LDL: low density lipoprotein; eGFR:
assessment-insulin resistance; hsCRP: high-sensitivity C-reactive protein; CIMT: carot
ABI: ankle-brachial index.(Table 4). Mean CIMT and baPWV in the third tertile
group of a brachial PP were significantly higher than those
levels in the first and second tertile group (p = 0.03,
p < 0.01). Mean carotid IMT levels among tertile groups
of central SBP and brachial SBP were not different
(data not shown).
Prevalence of diabetic microvascular complications
according to the tertile levels of central PP or brachial PP
Comparisons of the prevalence of diabetic micro-
vascular complications according to the tertile levels
of central PP or brachial PP are shown in Figure 2.
The prevalence of nephropathy and retinopathy accor-
ding to the brachial PP tertiles significantly increased
(21% vs 20% vs 44%, p = 0.006; 19% vs 22% vs 51%,
p = 0.002, respectively). The prevalence of DPN and
CAN did not show significant differences according
to the brachial PP tertiles. The prevalence of diabetic
microvascular complications did not differ across central
PP tertiles.ording to the tertile levels of central PP
2nd tertile 3rd tertile P for trend
48.6 ± 2.8 63.7 ± 10 0.001
122.1 ± 10.4 135.9 ± 13.8 <0.01
121.7 ± 11.4 132.0 ± 15.1 <0.01
73.4 ± 9.8 72.2 ± 10.2 0.53
48.2 ± 7.3 59.7 ± 10.6 <0.01
54.2 ± 10.3 59.7 ± 10.6 <0.01
25.1 ± 2.7 24.7 ± 3.2 0.67
7.3 ± 6.4 10.5 ± 9.2 0.02
7.5 ± 1.5 7.6 ± 1.9 0.75
164.6 ± 37.6 166 ± 36.7 0.27
133 (88, 185) 114 (77, 144) 0.35
47.6 ± 13.2 48.5 ± 13.7 0.67
93.4 ± 34.8 98.9 ± 31.4 0.45
78.5 ± 19 69.5 ± 16 0.01
0.69
52 (34.8) 42 (28.2)
12 (31.6) 13 (44.4)
4 (34.2) 3 (33.3)
2.9 (2.0, 4.1) 2.9 (1.9, 5.0) 0.92
0.08 (0.04, 0.18) 0.1 (0.05,0.25) 0.35
0.62 ± 0.13 0.66 ± 0.15 0.014
1581 ± 495 1751 ± 359 <0.01
1.15 ± 0.06 1.15 ± 0.06 0.02
s).
iastolic blood pressure; BMI: body mass index; DM: diabetes mellitus; HbA1c:
estimated glomerular filtration rate; HOMA-IR: homeostasis model
id intima-media thickness; baPWV: brachial-ankle pulse wave velocity;
Table 4 Difference of mean values of the clinical variables according to the tertile levels of brachial PP
1ST tertile 2nd tertile 3rd tertile P for trend
Central PP (mmHg) 40.1 ± 6.6 47.5 ± 7.0 60.6 ± 14.6 <0.01
Central SBP (mmHg) 113.2 ± 13 119.9 ± 12.3 132 ± 19.1 <0.01
Brachial SBP (mmHg) 110.9 ± 11.6 120 ± 9.8 133.5 ± 15.5 <0.01
Brachial DBP (mmHg) 73.1 ± 9.6 72.4 ± 9.4 71.3 ± 10.9 0.3
Brachial PP (mmHg) 37.8 ± 4.3 47.6 ± 2.1 62.1 ± 10.2 <0.01
Age (years) 50.5 ± 9 54.6 ± 10.7 62.4 ± 10.8 <0.01
BMI (kg/m2) 24.5 ± 3.2 25.5 ± 3 24.7 ± 3 0.82
Duration of DM (years) 6.1 ± 5.1 7.7 ± 5.7 11.8 ± 9.9 <0.01
HbA1C (%) 7.8 ± 1.6 7.6 ± 1.8 7.5 ± 1.5 0.3
Total cholesterol (mg/dL) 159 ± 35.7 159.3 ± 36.4 170.6 ± 35.8 0.09
Triglycerides (mg/dL) 123 (80, 162) 121 (91, 181) 117 (81, 153) 0.69
HDL-C (mg/dL) 47.4 ± 11 46.6 ± 12.1 50.2 ± 15.9 0.26
LDL-C (mg/dL) 93.6 ± 32.9 90.5 ± 32.7 101.4 ± 33.4 0.28
eGFR (mL/min/1.73 m2) 82.2 ± 16 78.1 ± 14.9 67.2 ± 19.8 <0.01
Diabetic nephropathy, n (%) 0.02
No albuminuria 56 (37.6) 53 (35.6) 40 (26.8)
Microalbuminuria 11 (28.9) 10 (26.3) 17 (44.7)
Overt proteinuria 2 (22.2) 1 (11.1) 6 (66.7)
HOMA-IR 2.4 (1.7, 4.5) 2.9 (2.2, 4.8) 2.7 (1.9, 3.9) 0.97
hsCRP (mg/dL) 0.08 (0.05, 0.18) 0.09 (0.04, 0.16) 0.09 (0.05, 0.22) 0.68
Mean CIMT (mm) 0.58 ± 0.11 0.63 ± 0.16 0.75 ± 0.14 0.03
Mean PWV (cm/sec) 1370 ± 205 1587 ± 537 1752 ± 341 <0.01
Mean ABI 1.14 ± 0.05 1.14 ± 0.07 1.14 ± 0.08 0.74
Data are shown as mean ± SD, median (interquartile range) or number (percentages).
PP: pulse pressure; SBP: systolic blood pressure; SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; DM: diabetes mellitus; HbA1c:
hemoglobin A1c; HDL: high density lipoprotein; LDL: low density lipoprotein; eGFR: estimated glomerular filtration rate; HOMA-IR: homeostasis model
assessment-insulin resistance; hsCRP: high-sensitivity C-reactive protein; CIMT: carotid intima-media thickness; baPWV: brachial-ankle pulse wave velocity; ABI:
ankle-brachial index.
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presence of each diabetic microvascular complications
Differences of several parameters of BP according to the
presence or absence of microvascular complications are




Figure 2 Prevalence of diabetic microangiopathies according to the tbrachial SBP and brachial PP were detected in patients
with DN compared to those without DN (p = 0.02 and
p = 0.01, respectively). In patients with DR, brachial
SBP and brachial PP were significantly higher than in




ertile levels of the PP. (A) Brachial PP. (B) Central PP.
Table 5 Blood pressure according to the presence of each microangiopathies
DR DN DPN
(−) (+) p (−) (+) p (−) (+) p
Central SBP 119.5 ± 15.7 123.6 ± 20 0.22 120.4 ± 14.6 123.9 ± 17.8 0.20 123.2 ± 13.6 121.5 ± 21.3 0.73
Central PP 47.7 ± 11.4 53 ± 17.4 0.08 47.8 ± 11.8 51.5 ± 13.9 0.09 49.8 ± 11.4 52 ± 15.3 0.53
Brachial SBP 117.8 ± 13.6 124.7 ± 17 0.02 119.2 ± 13.9 125 ± 15.7 0.02 121.6 ± 13 122 ± 20.6 0.93
Brachial PP 46 ± 8.9 54.2 ± 15 0.03 46.6 ± 10.1 52.6 ± 13.1 0.01 48.3 ± 10.2 52.5 ± 15.1 0.21
Data are shown as mean ± SD.
DR: diabetic retinopathy; DN: diabetic nephropathy; DPN: diabetic peripheral neuropathy.
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in patients with DN or DR and those without DN or
DR.
Multivariate logistic regression analysis for the
relationship of central or brachial blood pressure with
presence of diabetic retinopathy/nephropathy
Clinical variables showing significantly different values be-
tween the presence or absence of DR/DN were examined
by t-test (data not shown). Total cholesterol, LDL-choles-
terol, eGFR and mean baPWV levels were significantly dif-
ferent according to the presence or absence of DN.
HbA1C, duration of DM and mean baPWV levels were
significantly different according to the presence or absence
of DR. After adjustment for these variables, age and gen-
der, multivariate logistic regression analysis was done to
examine the relationship of central or brachial BP with
the presence of DR/DN (Table 6). In multivariate analysis,
only brachial PP among all BP components was signi-
ficantly associated with the presence of DR/DN. An in-
creased brachial PP independently increased the odds for
the presence of diabetic nephropathy and retinopathy.
The relative risks for the presence of DR were 1.2 and 4.6
for the brachial PP tertiles 2 and 3 when compared with
the first tertile (p = 0.003). Also, the relative risks for the
presence of DN were 1.02 and 3.0 for the brachial PP 2nd,
3rd tertiles when compared with first tertile (p = 0.01).
Higher HbA1C and longer duration of DM independently
increased the odds for the presence of DR (Table 6).
Discussion
To the best of our knowledge, our study is the first to
report associations between central versus brachial BP
with all diabetic microvascular complications as well as
carotid atherosclerosis.
The main finding of this study is that central BP and
brachial BP show very strong agreement. Nevertheless,
the higher brachial PP levels are associated with increased
probability for the presence of diabetic microvascular
complications and are more powerful than central BP in
relation to DR and DN. But, to the contrary, central BP
levels rather than brachial BP are correlated with surro-
gate marker of macrovascular complications.Peripheral (brachial) BP is an essential parameter for
the evaluation and management of BP and remains the
standard reference. On the other hand, there is increas-
ing evidence that measurement of central BP, reflecting
ascending aortic BP, is more strongly correlated to CVD
or TOD than brachial BP levels [4,25]. Although superior-
ity of central BP than brachial BP in relation to CVD or
TOD has been suggested in several studies, measurement
of central BP in real practice is not easy. Therefore, it is
meaningful to examine the relationship or concordance be-
tween central BP and brachial BP. In this study, agreement
between central BP and brachial BP was very strong as evi-
denced by the concordance correlation coefficient > 0.8.
High concordance values may indicate little difference be-
tween two BP components is present and these two can be
interchangeable.
Few studies have evaluated whether central and brachial
BP are associated differently with carotid atherosclerosis
and microvascular complications in patients with T2DM.
The Strong Heart Study revealed that central PP was more
strongly related to CIMT and plaque score than was
brachial PP in 3520 population (including diabetes in
46.5% of women and 38.1% of men) [4]. Central pressure
augmentation and aortic SBP, but not brachial SBP, were
age-independent determinants of CIMT in another study
[7]. To the contrary, whereas the superiority of central BP
relative to brachial BP in terms of its association with
TOD such as cardiac hypertrophy has been reported,
central and brachial BP levels are not reportedly different
in relation with cardiac hypertrophy [26]. In a recent
meta-analysis of 11 longitudinal studies, the relative risk
of any CV event was 1.088 ([1.040-1.139], n = 3285)
for an increase of central SBP by 10 mmHg and 1.137
([1.063-1.215], n = 4778) for an increase of central PP by
10 mmHg, but neither the RR associated with higher
central SBP nor the RR associated with higher central PP
differed significantly from the relative risks associated with
its brachial counterparts, respectively [27].
The present study revealed that central PP is signifi-
cantly correlated with CIMT and brachial PP values also
showed positive, but weaker, correlation than central PP.
The levels of mean CIMT demonstrated an increasing
trend as the levels of central PP or brachial PP increased.
Table 6 Multivariate logistic regression analysis with
presence or absence of diabetic nephropathy/retinopathy
as the dependent variable
(1) diabetic retinopathy as dependent variable
Independent variable Odds ratio (95% CI) P-value
Central SBP 0.65
1st tertile 1
2nd tertile 1.50 (0.60-3.77) 0.39
3rd tertile 1.44 (0.56-3.73) 0.45
Central PP 0.18
1st tertile 1
2nd tertile 0.89 (0.35-2.29) 0.81
3rd tertile 2.02 (0.80-5.15) 0.14
Brachial PP 0.003
1st tertile 1
2nd tertile 1.21 (0.44-3.54) 0.67
3rd tertile 4.59 (1.72-12.27) 0.002
Gender (Male) 1.85 (0.85-4.03) 0.12
Age 1.03 (0.99-1.07) 0.12
mean baPWV 1.01 (0.99-1.01) 0.91
HbA1C 1.85 (1.27-2.71) 0.002
Duration of DM 1.19 (1.09-1.30) 0.001
(2) diabetic nephropathy as dependent variable
Independent variable Odds ratio (95% CI) P-value
Central SBP 0.69
1st tertile 1
2nd tertile 1.28 (0.50-3.0) 0.57
3rd tertile 1.45 (0.60-3.40) 0.39
Central PP 0.61
1st tertile 1
2nd tertile 1.17 (0.52-2.64) 0.71
3rd tertile 1.52 (0.66-3.50) 0.33
Brachial PP 0.01
1st tertile 1
2nd tertile 1.02 (0.38-2.26) 0.86
3rd tertile 3.0 (1.32-6.80) 0.01
Age 1.02 (0.99-1.05) 0.25
Gender (Male) 1.11 (0.56-2.22) 0.76
mean baPWV 1.01 (0.99-1.01) 0.14
Total cholesterol 1.03(0.99-1.06) 0.18
LDL-cholesterol 0.98 (0.94-1.02) 0.35
SBP: systolic blood pressure; PP: pulse pressure; baPWV: brachial-ankle pulse
wave velocity; LDL: low density lipoprotein; HbA1c: hemoglobin A1c.
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not correlated with carotid atherosclerosis. In contrast
to this our study, Westerbacka et al. reported measures of
central SBP correlate with CIMT [7]. One report showedthat central SBP predicted CV mortality independently of
brachial SBP and traditional cardiovascular risk factors
(Hazard ratio per 10 mmHg increase in central SBP: 1.34
[1.107-1.612], whereas central PP did not predict CV
mortality independently of brachial PP and traditional CV
risk factors in 1272 Chinese people recruited from the
community [28].
PP, the arithmetic difference between systolic and dia-
stolic BP, has been reported as a potent predictor for
CVD [29]. Several studies pointed out that a CV risk in
subjects with wide PP increased with the presence of
diabetes [9]. In addition, PP is increased in patients with
intima-media thickening [11]. In our study, brachial PP
was significantly correlated with age, duration of diabetes,
baPWV and CIMT. Also, central PP was correlated with
age, estimated glomerular filtration ratio (eGFR), ABI,
baPWV and CIMT. Especially, central or brachial PP, but
not central or brachial SBP/DBP, was presently associated
with carotid atherosclerosis. However, the majority of pre-
vious studies did not compare the brachial PP and central
PP in relation to CV risk factors. Associations and clinical
values of several components of BP such as SBP, DBP,
mean BP and PP with CVD have been studied extensively.
However, it is not definitively identified whether one of
these measures is more strongly associated with CVD
than the other. Moreover, the answer to the question of
whether central BP provides value over and above periph-
eral BP in relation to CVD is still open.
Central BP can be directly measured only using a pres-
sure sensor or catheter inserted into the aorta. This pro-
cedure is invasive and can lead to complications. Recently,
central BP has been evaluated noninvasively by mathemat-
ically transforming the radial artery pulse waveform to the
aortic pulse waveform [15,16]. However, the clinical sig-
nificance of central BP, which can be measured easily by
automated applanation tonometry, has not been fully
elucidated. More data are needed to establish and differ-
entiate the clinical utility of central BP using automated
applanation tonometry or brachial BP as a surrogate
marker in predicting CV events in T2DM.
To our knowledge, no study has examined the relative
importance of central and brachial BP in their relations
to microvascular complications in patients with T2DM.
This present study examined the relationship between
central BP, brachial BP and all microvascular complica-
tions. We established good association higher brachial
PP levels and increased probability for the presence of
diabetic nephropathy and retinopathy. However, our study
showed that no associations of any central BP components
or brachial BP components with CAN and DPN. In agree-
ment of our study, Knudsen et al. reported that in 80
patients with T2DM, brachial PP is associated with DR
and DN [12]. Also, in another study, brachial PP was
reported as an important risk factor for eGFR decline and
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cially in patients with T2DM [13]. In contrast to our study,
brachial PP was not a risk factor for DN in T1DM [14].
One of the possible explanation for association PP and
microvascular complications such as DN and DR is that
elevated PP is associated with endothelial activation and
pertubation in patients with T2DM. Endothelial dysfunc-
tion could represent a pathophysiological link between
these wide PP and the development of microvascular
complications in T2DM [30]. However, the reasons
are not clear why central PP is not associated with any
diabetic microvascular complications. Prospective data on
the predictive value of central BP for microvascular com-
plications, such as renal outcome and retinal vascular
impairment in diabetic patients, are currently lacking. The
ongoing LOD-DIABETES study is expected to answer this
question [31]. Also, it is not clear the reason why brachial
PP is not associated with DPN and CAN. A possible
explanation can be suggested. Regarding to the patho-
genesis of DPN, several important mechanisms, such as
glycemic control and duration of diabetes, have been re-
lated. Although roles of CV risk factors such as hyperten-
sion have been proposed, the effect of BP on pathogenesis
of DPN may be not more prominent than other traditional
risk factors of DPN [32].
Several limitations of our study should be addressed.
First, due to the cross-sectional design, we cannot deter-
mine the causative relationship between brachial PP and
diabetic microvascular complications, DN or DR. Pro-
spective studies are required to address this important
question. Second, because our study population included
individuals who received the examination for diabetic
complications, some characteristics of the present study
population may be substantially different from other pop-
ulations that did not perform complication study. There-
fore, the generalizability of our study may be limited.
Third, the present study included a small numbers of sub-
jects. A larger number of patients should be analyzed for
the confirmation of our results. Fourth, information for
central BP is that derived from automated radial artery
tonometry. Although the clinical significance of central BP
by automated applanation tonometry, has not been fully
elucidated, many studies revealed that central BP from
radial artery automated tonometry showed excellent cor-
relation with direct measured central BP [33]. However,
our study is meaningful in that this is the first study for
the evaluation of relationships between central versus
brachial BP with all diabetic microvascular complications
as well as vascular stiffness and carotid atherosclerosis in
patients with T2DM.
Conclusions
In conclusion, this study showed that agreement of
central BP and brachial BP was very strong. Brachial BPare associated with presence of microvascular complica-
tions such as DR/DN than central BP. On the other
hand, central BP levels rather than brachial BP are
correlated with surrogate marker of macrovascular
complication. However, further prospective studies are
needed to evaluate the superiority or difference of
central BP versus brachial BP in respective of associa-
tions with development of micro-and macrovascular
complications in T2DM.
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